Howard Capital Management Group’s Novo Nordisk NVO Stock Holding History

Howard Capital Management Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,022	Closed	-$209K	–	145
2025 Q2	$209K	Hold	3,022	–	–	0.01%	123
2025 Q1	$210K	Hold	3,022	–	–	0.02%	117
2024 Q4	$260K	Hold	3,022	–	–	0.02%	111
2024 Q3	$360K	Buy	3,022 +22	+0.7%	+$2.93K	0.03%	97
2024 Q2	$428K	Hold	3,000	–	–	0.03%	87
2024 Q1	$385K	Hold	3,000	–	–	0.03%	90
2023 Q4	$310K	Hold	3,000	–	–	0.03%	87
2023 Q3	$273K	Hold	3,000	–	–	0.03%	86
2023 Q2	$243K	Hold	3,000	–	–	0.02%	88
2023 Q1	$239K	Hold	3,000	–	–	0.03%	94
2022 Q4	$203K	Buy	+3,000	New	+$176K	0.02%	93

Other funds holding NVO

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Howard Capital Management Group's NVO Position: Q3 2025 in Review

Howard Capital Management Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,022 shares — an estimated $209K sold.

Howard Capital Management Group first reported a position in NVO in Q4 2022 and held it in 11 quarters. The position peaked at $428K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

Howard Capital Management Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
Howard Capital Management Group sold 3,022 Novo Nordisk shares in Q3 2025, an estimated $209K.
Howard Capital Management Group first reported a position in Novo Nordisk in Q4 2022 and held it in 11 quarters.
Howard Capital Management Group's Novo Nordisk position peaked at $428K in Q2 2024.
1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Howard Capital Management Group's 13F filing for Q3 2025, filed 16 Oct 2025.